Recent News for CNBX - Cannabics Pharmaceuticals Inc

Date Title
Jun 16 Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors
Jun 10 Cannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting Cancers
May 26 Cannabics Pharmaceuticals to Capitalize on Israel's Final Approval for the Export of Medical Cannabis
May 6 Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids
Apr 27 Cannabics Pharmaceuticals Appoints Prof. Zamir Halpern to Its Scientific Board of Advisors
Apr 13 Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer
Mar 25 Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids
Mar 18 Cannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 Research
Mar 11 Cannabics Pharmaceuticals Shows Specific Cultivars Identified to Have Positive Anti-Tumor Effects on Gastric Adenocarcinoma
Mar 2 Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
Feb 25 Cannabics Pharmaceuticals Partners With NewCanna to Commence Research Based on Colombian Indigenous Cannabis Landraces
Feb 18 Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
Feb 11 Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers
Jan 27 Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit
Jan 9 Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties

Back to the Main CNBX Page...